CIK 0001527753 · Non-accelerated filer<br>Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275411038
- Phone
- 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 53,750 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Scientific Officer sold 40,000 shares at an average $25.69 ($1,027,592)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Chief Scientific Officer sold 1,130 shares at $26.73 ($30,205)
- 4 Open-market sale Chief Financial Officer sold 2,446 shares at $26.73 ($65,382)
- 4 Grant or award Director acquired 2,610 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Chief Financial Officer sold 3,022 shares at $32.60 ($98,517)
Page 21 of 28 · 557 filings